ArticleHepatology communications2019
Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma.
Open access · goldAbstract read
In one paragraph
Article in Hepatology communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 33 citations in OpenAlex.
- Article
- EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Extracellular Adenosine in Gastric Cancer: The Role of GCSCs.International journal of molecular sciences · 2025Article
- The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment.European journal of immunology · 2025Review
- Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.Journal of experimental & clinical cancer research : CR · 2025Review
- Article
- Sweet regulation - The emerging immunoregulatory roles of hexoses.Journal of advanced research · 2025Review
- CD73: a new immune checkpoint for leukemia treatment.Frontiers in immunology · 2025Review
- Article
- Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma.Biomolecules · 2024Article
- Methods for quantification of glycopeptides by liquid separation and mass spectrometry.Mass spectrometry reviews · 2023Review
- Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.Current opinion in pharmacology · 2022Review
- Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity.Purinergic signalling · 2022Article
- Development of a metabolism-related signature for predicting prognosis, immune infiltration and immunotherapy response in breast cancer.American journal of cancer research · 2022Article
- The ubiquitin-specific peptidase 22 is a deubiquitinase of CD73 in breast cancer cells.American journal of cancer research · 2022Article
- The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).Trends in cell biology · 2021Review
- All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members.Genes & diseases · 2021Article
- Glycosylation of Immune Receptors in Cancer.Cells · 2021Review
- Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer.Cancer letters · 2021Article
- Targeting CD73 to augment cancer immunotherapy.Current opinion in pharmacology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 1 country.
Karel P AlcedoDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.
Andres GuerreroDepartment of Chemistry University of California Davis Davis CA.
Venkatesha BasrurDepartment of Pathology University of Michigan Ann Arbor MI.
Dong FuDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.ORCID https://orcid.org/0000-0002-6865-5033
Monea L RichardsonDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.
Joshua S McLaneDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.
Chih-Chiang TsouDepartment of Computational Medicine and Bioinformatics University of Michigan Ann Arbor MI.
Alexey I NesvizhskiiDepartment of Pathology University of Michigan Ann Arbor MI.
Theodore H WellingPerlmutter Cancer Center and Department of Surgery New York University Langone Health New York NY.
Carlito B LebrillaDepartment of Chemistry University of California Davis Davis CA.
Carol A OteyDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.
Hong Jin KimDepartment of Surgery University of North Carolina at Chapel Hill Chapel Hill NC.
M Bishr OmaryDepartment of Molecular and Integrative Physiology University of Michigan Ann Arbor MI.
Natasha T SniderDepartment of Cell Biology and Physiology University of North Carolina at Chapel Hill Chapel Hill NC.ORCID https://orcid.org/0000-0001-7663-4585
University of North Carolina at Chapel Hill · USUniversity of Michigan · USUniversity of California, Davis · USNYU Langone Health · USRutgers, The State University of New Jersey · US
Funding
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5MUniversity of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1986 to 2021
$22.5MKeratin Biology and Disease Aspects in Simple EpitheliaR01DK047918 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1995 to 2018
$6.6MThe incorporation of human milk oligosaccharides in brain glycoconjugatesR01GM049077 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEBRILLA, CARLITO B · 1999 to 2024
$6.3MUNC PREP in the Biomedical Sciences - Administrative SupplementR25GM089569 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBINSON, DONITA L, RODRIGUEZ-ROMAGUERA, JOSE · 2010 to 2024
$5.6MCOMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4MCANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0MUniversity of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1MMechanism of Proteotoxicity and Experimental Therapeutic Approaches in PorphyriaR01DK116548 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bishr Omary · 2017 to 2026
$3.8MCD73 is a multi-functional protein that regulates liver injuryR01DK110355 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SNIDER, NATASHA T · 2017 to 2021
$1.8MNCI NIH HHS T32 CA071341NCI NIH HHS U24 CA210967NIDDK NIH HHS P30 DK034933NIDDK NIH HHS P30 DK034987NIDDK NIH HHS R01 DK047918NIDDK NIH HHS R01 DK110355NIDDK NIH HHS R01 DK116548NIGMS NIH HHS R01 GM049077NIGMS NIH HHS R01 GM094231
Abstract
CD73, a cell-surface
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.